MCAC Executive Committee Requests Guidance On Cost Effectiveness
This article was originally published in The Gray Sheet
Executive Summary
The executive steering committee of the Medicare Coverage Advisory Committee is seeking clear instruction from the Health Care Financing Administration on whether cost effectiveness should be considered by the expert panels charged with making coverage recommendations.
You may also be interested in...
HCFA Letter To HIMA Supports Strong Role For MCAC Executive Committee
The executive committee of the Medicare Coverage Advisory Committee can "give advice to the [MCAC] panels on the relative weight to be accorded to various types of evidence," the Health Care Financing Administration asserts in a Jan. 12 letter to Brad Thompson, legal counsel for the Health Industry Manufacturers Association.
HCFA Letter To HIMA Supports Strong Role For MCAC Executive Committee
The executive committee of the Medicare Coverage Advisory Committee can "give advice to the [MCAC] panels on the relative weight to be accorded to various types of evidence," the Health Care Financing Administration asserts in a Jan. 12 letter to Brad Thompson, legal counsel for the Health Industry Manufacturers Association.
LVRS Reimbursement Study On 12-Year Pace Based On Current Enrollment
A HCFA/NIH study to gather data on lung volume reduction surgery (LVRS) will take 12 years to complete rather than the projected seven, attorney Michael Gaba, of the law firm of Oppenheimer Wolff Donnelly & Bayh, suggested Dec. 6 at the Medical Device Manufacturers Association's Second Annual Coverage and Reimbursement Conference in Philadelphia, Pennsylvania.